AstraZeneca Sells $2.2 Billion Worth COVID-19 Vaccines: Report

Drugmaker AstraZeneca reported that it sold more than $2.2 billion worth of COVID-19 vaccines in the past nine months. Earlier, the company promised to provide jabs on a not-for-profit basis through the pandemic. However, the company is expecting to progressively transition the vaccine to 'profitability'. AstraZeneca also reported that it will be creating more vaccine units under its plans for the future of the Pandemic.